Invesaro

Stocks CNTB Earnings

Earnings

Connect Biopharma Holdings Ltd (CNTB) earnings

Quarterly results of Connect Biopharma Holdings Ltd as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when CNTB files with the SEC.

Next earnings date

Connect Biopharma Holdings Ltd is expected to report around November 11, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) Connect Biopharma Holdings Ltd reported revenue of $2.8M (+5,666.7% on the same quarter a year earlier) and a net loss of $17.3M.

Diluted earnings per share were -$0.27.

Filed with the SEC on August 12, 2026.

Revenue by quarter
Q3 24: $1.2M $1.2M Q3 24Q1 25: $0 $0 Q1 25Q2 25: $48K $48K Q2 25Q3 25: $16K $16K Q3 25Q4 25: $0 $0 Q4 25Q1 26: $169K $169K Q1 26Q2 26: $2.8M $2.8M Q2 26
Net income by quarter
Q3 24: -$12.9M -$12.9M Q3 24Q4 24: -$8.9M -$8.9M Q4 24Q1 25: -$10.3M -$10.3M Q1 25Q2 25: -$12.9M -$12.9M Q2 25Q3 25: -$17.2M -$17.2M Q3 25Q4 25: -$15.1M -$15.1M Q4 25Q1 26: -$19.4M -$19.4M Q1 26Q2 26: -$17.3M -$17.3M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026$2.8M+5,666.7%-$17.3M-$0.27
Q1 FY2026March 31, 2026$169K--$19.4M-$0.34
Q4 FY2025December 31, 2025$0--$15.1M-
Q3 FY2025September 30, 2025$16K-98.7%-$17.2M-$0.31
Q2 FY2025June 30, 2025$48K--$12.9M-$0.23
Q1 FY2025March 31, 2025$0--$10.3M-$0.19
Q4 FY2024December 31, 2024---$8.9M-
Q3 FY2024September 30, 2024$1.2M--$12.9M-$0.23

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Connect Biopharma Holdings Ltd's next earnings date?

Connect Biopharma Holdings Ltd is expected to report around November 11, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Connect Biopharma Holdings Ltd's latest quarterly results?

For Q2 FY2026, which ended June 30, 2026, Connect Biopharma Holdings Ltd reported revenue of $2.8M and a net loss of $17.3M. The figures come from its filing with the SEC.

Is Connect Biopharma Holdings Ltd's revenue growing?

Revenue in Q2 FY2026 was $2.8M, up 5,666.7% from $48K in the same quarter a year earlier.

Get an email when CNTB reports

Follow CNTB and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when CNTB files with the SEC.

Source: quarterly figures Connect Biopharma Holdings Ltd tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Connect Biopharma Holdings Ltd